IGFBP7 and the Tumor Immune Landscape: A Novel Target for Immunotherapy in Bladder Cancer

Insulin-like growth factor binding protein-7 (IGFBP7) was recently reported to be a ligand of CD93, a potential target to normalize vasculature and attenuate immunotherapy. However, its role in the tumor microenvironment (TME) and immunotherapy response of bladder cancer (BLCA) remains unclear. We c...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Xianyanling, Zheng, Xiaonan, Xu, Hang, Li, Jin, Zhang, Tianyi, Ge, Peng, Liao, Dazhou, Li, Hong, Lyu, Xiaoyan, Ai, Jianzhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259832/
https://www.ncbi.nlm.nih.gov/pubmed/35812369
http://dx.doi.org/10.3389/fimmu.2022.898493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259832/
https://www.ncbi.nlm.nih.gov/pubmed/35812369
http://dx.doi.org/10.3389/fimmu.2022.898493

Ejemplares similares